| ［1］ |
Selkoe DJ.Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein［J］.Journal of Alzheimer'sdisease,2001,3(1):75-80.
|
| ［2］ |
Amatniek JC,Hauser WA,DelCastillo-Castaneda C,et al.Incidence and predictors of seizures in patients with Alzheimer's disease［J］.Epilepsia,2006,47(5):867-872.
|
| ［3］ |
Palop JJ,Mucke L.Epilepsy and cognitive impairments in Alzheimer disease［J］.Archives of neurology.2009,66(4):435-440.
|
| ［4］ |
Harris JA,Devidze N,Verret L,et al.Transsynaptic progression of amyloid-beta-induced neuronal dysfunction within the entorhinal-hippocampal network［J］.Neuron,2010,68(3):428-441.
|
| ［5］ |
Minkeviciene R,Rheims S,Dobszay MB,et al.Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy［J］.The Journal of Neuroscience,2009,29(11):3453-3462.
|
| ［6］ |
Roberson ED,Halabisky B,Yoo JW,et al.Amyloid-beta/Fyninduced synaptic,network,and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease［J］.The Journal of Neuroscience,2011,31(2):700-711.
|
| ［7］ |
Palop JJ,Chin J,Roberson ED,et al.Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease［J］.Neuron,2007,55(5):697-711.
|
| ［8］ |
Vogt DL,Thomas D,Galvan V,et al.Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain［J］.Neurobiology of aging,2011,32(9):1725-1729.
|
| ［9］ |
Ziyatdinova S,Gurevicius K,Kutchiashvili N,et al.Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels［J］.Epilepsy research,2011,94(1-2):75-85.
|
| ［10］ |
Sanchez PE,Zhu L,Verret L,et al.Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer’s disease model［J］.Proc Natl Acad Sci USA,2012,109(42):2895-2903.
|
| ［11］ |
Cumbo E,Ligori LD.Levetiracetam,lamotrigine,and phenobarbital in patients withepileptic seizures and Alzheimer’sdisease［J］.Epilepsy Behav,2010,17(4):461-466.
|
| ［12］ |
Huang Y,Mucke L.Alzheimer mechaisms and therapeutic strategies［J］.Cell,2012,148(6):1204-1222.
|
| ［13］ |
Cai H,Wang D,McCarthy H,et al.BACE1 is the major beta-secretase for generation of Abeta peptides by neurons［J］.Nat Neurosci,2001,4(3):233-234.
|
| ［14］ |
Hsieh H,Boehm J,Sato C,et al.AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss［J］.Neuron,2006,52(5):831-843.
|
| ［15］ |
Palop J.J,Chin J,Mucke L.A network dysfunction perspective on neurodegenerative diseases［J］.Nature,2006,443(7113):768-773.
|
| ［16］ |
Verret L,Mann EO,Hang GB,et al.Inhibitory interneuron de ficit links altered networkactivity and cognitive dysfunction in Alzheimer model［J］.Cell,2012,149(3):708-721.
|
| ［17］ |
Meilandt WJ,Yu GQ,Chin J,et al.Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer’s disease［J］.J.Neurosci,28(19):5007-5017.
|
| ［18］ |
Palop JJ,Jones B,Kekonius L,et al.Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits［J］.Proc Natl Acad Sci U SA,2003,100(16):9572-9577.
|
| ［19］ |
Palop JJ,Chin J,Bien Ly N,et al.Vulnerability of dentate granule cells to disruption of Arc expressionin human amyloid precursor protein transgenic mice［J］.J Neurosci,2005,25(42):9686-9693.
|
| ［20］ |
Chin J,Palop JJ,Puoliväli J,et al.Fyn kinase induces synaptic and cognitive impairments in a transgenic mouse model of Alzheimer'sdisease［J］.JNeurosci,2005,25(42):9694-9703.
|
| ［21］ |
Bero AW,Yan P,Roh JH,et al.Neuronal activity regulates the regional vulnerability to amyloid deposition［J］.Nat Neurosci,2011,14(6):750-756.
|
| ［22］ |
Hong Qing,Guiqiong He,PhilipT.T.Ly,et al.Valproic acid inhibits Aβproduction,neuritic plaque formation,and behavioral deifcits in Alzheimer’s disease mouse models［J］.J.Exp.Med,2008,205(12):2781-2789.
|
| ［23］ |
The Alzheimer disease and frontotemporal dementia mutation database.Flanders Interuniversity Institute for Biotechnology Department of Molecular Genetics Web site;2008.
|
| ［24］ |
Amatniek JC,Hauser WA,Delcastillo-Castaneda C,et al.Incidence and predictors of seizures in patients with Alzheimer’sdisease［J］.Epilepsia,2006,47(5):867-872.
|
| ［25］ |
Larner AJ,Doran M.Clinical phenotypic heterogeneity of Alzheimer's disease associated with mutations of thepresenilin-1 gene［J］.JNeurol,2006,253(2):139-158.
|
| ［26］ |
Snider BJ,Norton J,Coats MA,et al.Novel presenilin 1 mutation(S170F)causing Alzheimer disease with Lewy bodies in the third decade of life［J］.Arch Neurol,2005,62(12):1821-1830.
|
| ［27］ |
Palop JJ,Mucke L.Amyloid-βInduced Neuronal Dysfunction in Alzheimer’s Disease:From Synapses toward Neural Networks［J］.Nat Neurosci,2010,13(7):812-818.
|
| ［28］ |
Mahley RW,Weisgraber KH,Huang Y.Apolipoprotein E4:a causative factor and therapeutic target in neuropathology,including Alzheimer's disease［J］.Proc Natl Acad Sci U S A,2006,103(15):5644-5651.
|
| ［29］ |
Ponomareva NV,Korovaitseva GI,Rogaev EI.EEG alterations in non-demented individuals related to apolipoprotein E genotype and to risk of Alzheimer disease［J］.Neurobiol Aging,2008,29(6):819-827.
|
| ［30］ |
Ponomareva NV,Selesneva ND,Jarikov GA.EEG alterations in subjects at high familial risk for Alzheimer's disease.Neuropsychobiology,2003,48(3):152-159.
|
| ［31］ |
Vossel KA,Beagle AJ,Rabinovici GD,et al.Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease［J］.JAMA Neurol,2013,70(9):1158-1566.
|
| ［32］ |
Koh MT,Haberman RP,Foti S,et al.Treatment strategies targeting excess hippocampal activity benefit aged rats with cognitive impairment［J］.Neuropsychopharmacology,2010,35(4):1016-1025.
|
| ［33］ |
Bakker A,Krauss GL,Albert MS,et al.Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitiveimpairment［J］.Neuron,2012,74(3):467-474.
|
| ［34］ |
Cumbo E,Ligori LD.Levetiracetam,lamotrigine,and phenobarbital in patients withepileptic seizures and Alzheimer’sdisease［J］.Epilepsy Behav,2010,17(4):461-466.
|
| ［35］ |
Mendez M,Lim G.Seizures in elderly patients with dementia:epidemiology and management［J］.Drugs Aging,2003,20(11):791-803.
|
| ［36］ |
Fleisher AS,Truran D,Mai JT,et al.Alzheimer’s Disease Cooperative Study.Chronic divalproex sodium use and brain atrophy in Alzheimer disease［J］.Neurology,2011,77(13):1263-1271.
|
| ［37］ |
Tariot PN,Schneider LS,Cummings J,et al.Alzheimer’s Disease Cooperative Study Group.Chronic divalproex sodium to attenuate agitation and clinical progression of Alzheimer disease［J］.Arch Gen Psychiatry,2011,68(8):853-861.
|
| ［38］ |
Irizarry MC,Jin S,He F,et al.Incidence of new-onset seizures in mild to moderate Alzheimer disease［J］.Arch Neurol,2012,69(3):368-372.
|
| ［39］ |
Bakker A,Krauss GL,Albert MS,et al.Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitiveimpairment［J］.Neuron,2012,74(3):467-474.
|
| ［40］ |
Meehan AL,Yang X,McAdams BD,et al.A new mechanism for antiepileptic drug action:vesicular entry may mediate the effects of levetiracetam［J］.J Neurophysiol,2011,106(3):1227-1239.
|
| ［41］ |
Shi JQ,Wang BR,Tian YY,et al.Antiepileptics topiramate and levetiracetam alleviate behavioral deficits and reduce neuropathology in APPswe/PS1dE9 transgenic mice［J］.CNS Neurosci Ther,2013,19(11):871-881.
|
| ［42］ |
Cardinale JP,Sriramula S,Pariaut R,et al.HDAC inhibition attenuates inflammatory,hypertrophic,and hypertensive responses in spontaneously hypertensive rats［J］.Hypertension,2010,56(3):437-444.
|
| ［43］ |
Kochanek AR,Fukudome EY,Li Y,et al.Histone deacetylase inhibitor treatment attenuates MAP kinase pathway activation and pulmonary inflammation following hemorrhagic shock in a rodent model［J］.JSurg Res2011,176(1):185-194.
|
| ［44］ |
Kim HJ,Rowe M,Ren M,et al.Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke:Multiple mechanisms of action［J］.JPharmacol Exp Ther,2007,321(3):892-901.
|
| ［45］ |
Suh HS,Choi S,Khattar P,et al.Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes［J］.J Neuroimmune Pharmacol,2010,5(4):521-532.
|
| ［46］ |
Mark RJ,Ashford JW,Goodman Y,et al.Anticonvulsants attenuate amyloid beta-peptide neurotoxicity,Ca2+deregulation,and cytoskeletalpathology［J］.Neurobiol Aging,1995,16(2):187-198.
|
| ［47］ |
Angehagen M,Margineanu DG,Ben-Menachem E,et al.Levetiracetam reduces caffeine-induced Ca2+transients and epileptiform potentials in hippocampal neurons［J］.Neuroreport,2003,14(3):471-475.
|
| ［48］ |
Pisani A,Bonsi P,Martella G,et al.Intracellular calcium increase in epileptiform activity:Modulation by levetiracetam and lamotrigine［J］.Epilepsia,2004,45(7):719-728.
|
| ［49］ |
Chen PS,Wang CC,Bortner CD,et al.Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide induced dopaminergic neurotoxicity［J］.Neuroscience,2007,149(1):203-212.
|